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Melanoma is widely known as a malignant and detrimental cancer that develops from the 
pigment-producing cells known as melanocytes. The human leukocyte antigen (HLA) is an 
important signaling molecule encoded by the major histocompatibility complex (MHC) that allows 
the immune system to detect and destroy cancer cells. I conducted various experiments using the 
epigenetic modifier drugs 5-Azacytidine and Vorinostat as well as the cytokine known as gamma 
interferon. 5-Azacytidine is a methylation inhibitor, and Vorinostat is a histone deacetylase 
inhibitor. Interferon gamma influences downstream gene expression. The purpose of using these 
drugs was to see if there was an effect on HLA expression of the 435 Melanoma cell line. 
Numerous flow cytometry experiments were conducted to determine if these drugs had any effect 
on the HLA expression on the 435-cell line. The data suggests that both Vorinostat and 
5-Azacytidine increased HLA expression on the 435-cell line. Future experiments will be 
conducted to test whether the addition of gamma interferon to these drugs will result in an 
additional, synergistic, or antagonistic effect on the HLA expression. 
Introduction
Hypothesis: The addition of Gamma Interferon to 5-Azacytidine and Vorinostat 
treatment would increase HLA expression rather than with just Vorinostat and 
5-Azacytidine alone.
❖ I found that Gamma Interferon, Vorinostat, and 5-AZA increased 
upregulation of HLA-ABC expression when treated alone.
❖ The combination of 5-AZA with interferon or Vorinostat and 
gamma interferon did not increase HLA-ABC expression
❖ Unfortunately, my hypothesis was not supported
Future Studies
❖ We wish to test different epigenetic modifiers with Gamma 
Interferon to see if there would be any benefit for the HLA 
expression with the 435 Melanoma Cancer Cell Line.
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Figure 2A: Shows the mean HLA expression treated with Gamma Interferon alone. 
Figure 2B: Shows the mean HLA expression treated with Vorinostat alone. Figure 
2C: Shows the mean HLA expression treated with both Vorinostat and Gamma 
Interferon.
              
Figure 1A: This figure shows the mean HLA expression treated with 
Gamma Interferon alone. Figure 1B. Shows the mean HLA expression 
treated with 5-Azacytidine  alone. Figure 1C: Shows the mean HLA 
expression of Gamma Interferon and 5-5-Azacytidine together
5-AZA Results
Figure A: This figure shows that Gamma Interferon is a cytokine that stimulates the  jak stat 
pathway, leading to a transcription factor that induces many genes involved in the immune 
response
Figure B: This figure shows that 5-Azacytidine is a DNA methyltransferase inhibitor 
Figure C: This figure shows Vorinostat, a histone deacetylase which functions to maintain more U 




Table  1 and 2 show an additional experiments 5 that were performed through flow cytometry using 
Vorinostat and 5-Azacytidine as the treatments. The (-) indicate that treatment was not used for that 
experiment.  
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